Provided by Tiger Fintech (Singapore) Pte. Ltd.

JBM HEALTHCARE

2.840
-0.040-1.39%
Volume:38.00K
Turnover:108.62K
Market Cap:2.33B
PE:12.72
High:2.880
Open:2.880
Low:2.840
Close:2.880
52wk High:3.302
52wk Low:1.169
Shares:822.00M
HK Float Shares:822.00M
Volume Ratio:0.30
T/O Rate:0.00%
Dividend:0.17
Dividend Rate:5.99%
EPS(LYR):0.223
ROE:18.55%
ROA:9.95%
PB:2.16
PE(LYR):12.72
PS:2.98

Loading ...

JBM (Healthcare) Limited (2161 HK) Announces Board Meeting to Review Interim Results

Bulletin Express
·
Nov 05

JBM (Healthcare) Ltd. Board to Review Interim Results and Potential Dividend

Reuters
·
Nov 05

JBM (Healthcare) Limited (Stock Code: 02161) Announces Monthly Return for October 2025

Bulletin Express
·
Nov 03

Jacobson Pharma (2633) and JBM (Healthcare) (2161) Announce 2025 Europharm License Agreement

Bulletin Express
·
Oct 28

Jacobson Pharma (02633) and JBM Healthcare (02161): ULFERTS and ULFERTS (Hong Kong) Enter into 2025 Licensing Agreement

Stock News
·
Oct 28

Jacobson Pharma Signs 2025 Europharm License Agreement

Reuters
·
Oct 28

JBM (Healthcare) Signs 2025 Europharm License Agreement

Reuters
·
Oct 28

JBM HEALTHCARE (02161): Xu Hongxi Appointed as Non-Executive Director

Stock News
·
Sep 30

JBM (Healthcare) Ltd. Appoints Dr. Xu Hong Xi as Non-Executive Director Effective October 2025

Reuters
·
Sep 30

JBM (Healthcare) Ltd. Conducted Its Annual General Meeting

Reuters
·
Jul 28

JBM (Healthcare) Ltd. Announces Executive Director Resignation and Appointment of New Authorised Representative

Reuters
·
Jul 08

JBM (Healthcare) Ltd. Publishes 2024/2025 Annual Report

Reuters
·
Jul 03

JBM (Healthcare) Ltd. Announces Acquisition of Target Group to Enhance Chinese Medicine Portfolio

Reuters
·
Jun 16

JBM (Healthcare) Ltd. Proposes Final Dividend of HKD 0.115 Per Share for Year Ended 31 March 2025

Reuters
·
Jun 12

BRIEF-JBM (Healthcare) FY Net Income HKD 197.3 Million

Reuters
·
Jun 12

JBM (Healthcare) Ltd. Re-designates Non-Executive Directors Sum Kwong Yip and Yim Chun Leung to Executive Roles

Reuters
·
Jun 12

Jacobson Pharma Reports Over 40% Increase in FY2025 Profit from Continuing Operations; Profit Attributable to Shareholders Expected to Rise by Over 10%

Reuters
·
May 26

BRIEF-JBM (Healthcare) Says FY Consolidated Profit Expected To Increase By Not Less Than 50%

Reuters
·
May 20

JBM (Healthcare)'s Full-Year Profit to Balloon At Least 50%

MT Newswires Live
·
May 19

JBM (Healthcare) Ltd. Reports Over 50% Increase in Consolidated Profit Due to Strong Sales Performance

Reuters
·
May 19